1. Addition of abiraterone, docetaxel, bisphosphonate, celecoxib or combinations to androgen-deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC): a network meta-analysis. Issue 4 (November 2018) Authors: Tan, Pui; Aguiar, Pedro; Haaland, Benjamin; Lopes, Gilberto Journal: Prostate cancer and prostatic diseases Issue: Volume 21:Issue 4(2018) Page Start: 516 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗